Abstract
Cell aging involves damages and losses of genetic materials including the gradual shortening of telomeres. Telomeres, the ends of chromosomes, have a variety of functions, and the most notable ones include those involved in retaining genome integrity and stability and in regulating cell lifespan. Early loss or damage of telomeres causes premature aging, whereas excessive gain of telomeres confers immortality upon some cancer cells. However, the opposing changes in telomere structures and their associated cellular effects on aging and immortalization are forcefully regulated by the enzyme telomerase. Telomerase is a large protein-RNA complex that has telomeric DNA reverse transcriptase activity. Although a wealthy body of information has been obtained on the involvement of telomerase intumorigenesis, its structure of the holoenzyme, the mode of its action, its cellular function in aging, and the pathways of its regulatory mechanisms have not been entirely understood. Recent research on telomerase has become an increasing investigative effort to uncover the molecular mechanisms of aging and aging-related diseases. This article will briefly review now telomerase may impact aging, what potential in vivo significance the regulation of telomerase may have on aging, how signals are transduced from telomerase and telomere to different cellular effects, and how telomerase itself is controlled in mammalian cells.
Similar content being viewed by others
References
Aigner S, Lingner J, Goodrich KJ, Grosshans CA, Shevchenko A, MannMand Cech TR (2000) Euplotes telomerase contains an La motif protein produced by apparent translational frameshifting. Embo J 19: 6230-6239
Beattie TL, Zhou W, Robinson MO and Harrington L (1998) Reconstitution of human telomerase activity in vitro. Curr Biol 8: 177-180
Bodnar AG, Kim NW, Effros RB and Chiu CP (1996) Mechanism of telomerase induction during T cell activation. Exp Cell Res 228: 58-64
Bryan TM, Goodrich KJ and Cech TR (2000) Telomerase RNA bound by protein motifs specific to telomerase reverse transcriptase. Mol Cell 6: 493-499
Bryan TM, Sperger JM, Chapman KB and Cech TR (1998) Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc Natl Acad Sci USA 95: 8479-8484
Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, Greider CW and DePinho RA (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527-538
Counter CM, Meyerson M, Eaton EN and Weinberg RA (1997) The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 94: 9202-9207
Dang CV (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1-11
Dellambra E, Golisano O, Bondanza S, Siviero E, Lacal P, Molinari M, D'Atri S and De Luca M (2000) Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol 149: 1117-1130
Dessain SK, Yu H, Reddel RR, Beijersbergen RL and Weinberg RA (2000) Methylation of the human telomerase gene CpG island [in process citation]. Cancer Res 60: 537-541
Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC, Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A, Inoue M, Oh S, Song Y, Yim J and Kim TK (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene Estrogen activates telomerase The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. Cancer Res 59: 6087-6090
Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP and Rheinwald JG (2000) Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20: 1436-1447
Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J, Le S, West MD, Harley CB, Andrews WH, Greider CW and Villeponteau B (1995) The RNA component of human telomerase. Science 269: 1236-1241
Fu W, Begley JG, Killen MW and Mattson MP (1999) Antiapoptotic Role of Telomerase in Pheochromocytoma Cells. J Biol Chem 274: 7264-7271
Greenberg RA, Allsopp RC, Chin L, Morin GB and DePinho RA (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16: 1723-1730
Greider CW (1995) Telomerase biochemistry and regulation. In: Blackburn EH and Greider CW (eds) Telomeres, pp 35-68. Cold Spring Harbor Laboratory Press, Plainview, New York
Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H and de Lange T (1999) Mammalian telomeres end in a large duplex loop [see comments]. Cell 97: 503-514
Gunes C, Lichtsteiner S, Vasserot AP and Englert C (2000) Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res 60: 2116-2121
Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M and Weinberg RA (1999) Inhibition of telomerase limits the growth of human cancer cells [see comments]. Nat Med 5: 1164-1170
Harley CB, Futcher AB and Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460
Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I and Robinson MO (1997a) A mammalian telomeraseassociated protein. Science 275: 973-977
Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB and Robinson MO (1997b) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109-3115
Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC (1990) Telomere reduction in human colorectal carcinoma and with ageing [see comments]. Nature 346: 866-868
Huang P, Pryde FE, Lester D, Maddison RL, Borts RH, Hickson ID and Louis EJ (2001) SGS1 is required for telomere elongation in the absence of telomerase. Curr Biol 11: 125-129
Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC and Guarente L (2001) The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J 20: 905-913
Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H and Inoue M (2000) Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin Cancer Res 6: 1239-1247
Kang SS, Kwon T, Kwon DY and Do SI (1999) Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 274: 13085-13090
Karlseder J, Broccoli D, Dai Y, Hardy S and de Lange T (1999) p53-and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283: 1321-1325
Kharbanda S, Kumar V, Dhar S, Pandey P, Chen C, Majumder P, Yuan ZM, Whang Y, Strauss W, Pandita TK, Weaver D and Kufe D (2000) Regulation of the hTERT telomerase catalytic subunit by the c-Abl tyrosine kinase [in process citation]. Curr Biol 10: 568-575
Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR and Jefferson RA (1997) Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6: 2011-2019
Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells [see comments]. Nature 396: 84-88
Kolquist KA, Ellisen LW, Counter CM, Meyerson M, Tan LK, Weinberg RA, Haber DA and Gerald WL (1998) Expression of TERT in early premalignant lesions and a subset of cells in normal tissues [see comments]. Nat Genet 19: 182-186
Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK and Barna BP (1998) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J 12: 801-811
Ku WC, Cheng AJ and Wang TC (1997) Inhibition of telomerase activity by PKC inhibitors in human nasopharyngeal cancer cells in culture. Biochem Biophys Res Commun 241: 730-736
Kusumoto M, Ogawa T, Mizumoto K, Ueno H, Niiyama H, Sato N, Nakamura M and Tanaka M (1999) Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells [In Process Citation]. Clin Cancer Res 5: 2140-2147
Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H and Inoue M (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT) [In Process Citation]. Nucleic Acids Res 28: 669-677
Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW and DePinho RA (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574
Lendvay TS, Morris DK, Sah J, Balasubramanian B and Lundblad V (1996) Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 144: 1399-1412
Li H, Zhao L, Yang Z, Funder JW and Liu J-P (1998) Telomerase is controlled by protein kinase Calpha in human breast cancer cells. J Biol Chem 273: 33436-33442
Li H, Zhao LL, Funder JW and Liu J-P (1997) Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272: 16729-16732
Lindsey J, McGill NI, Lindsey LA, Green DK and Cooke HJ (1991) In vivo loss of telomeric repeats with age in humans. Mutat Res 256: 45-48
Lingner J and Cech TR (1996) Purification of telomerase from Euplotes aediculatus: Requirement of a primer 3' overhang. Proc Natl Acad Sci USA 93: 10712-10717
Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V and Cech TR (1997) Reverse transcriptase motifs in the catalytic subunit of telomerase [see comments]. Science 276: 561-567
Liu JP (2001) Molecular mechanisms regulating telomerase activity. In: Mattson MP and Pandita T (eds) Telomerase, Aging and Disease, pp. 33-59. Elsevier Science, Amsterdam
Liu J-P (1999) Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J 13: 2091-2104
Liu J-P (2000) Telomerase: Not just black and white, but shades of gray. Mol Cell Biol Res Commun 3: 129-135
Liu Y, Snow BE, Hande MP, Baerlocher G, Kickhoefer VA, Yeung D, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO and Harrington L (2000a) Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance In vivo [in process citation]. Mol Cell Biol 20: 8178-8184
Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO and Harrington L (2000b) The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 10: 1459-1462
Metcalfe JA, Parkhill J, Campbell L, Stacey M, Biggs P, Byrd PJ and Taylor AM (1996) Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 13: 350-353
Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA (1997) hEst2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795
Miller MC, Liu JK and Collins K (2000) Template definition by Tetrahymena telomerase reverse transcriptase. EMBO J 19: 4412-4422
Mitchell JR, Wood E and Collins K (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402: 551-555
Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521-529
Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human [see comments]. Science 277: 955-959
Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T and Ishikawa F (1998) Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68
Nguyen DC and Crowe DL (1999) Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity. Biochim Biophys Acta 1445: 207-215
Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y and Shinkai Y (1998) Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet 19: 203-206
Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N and Ishikawa F (1999) Presence of telomeric Gstrand tails in the telomerase catalytic subunit TERT knockout mice. Genes Cells 4: 563-572
Oh S, Song Y, Yim J and Kim TK (1999) TheWilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J Biol Chem 274: 37473-37478
Oh S, Song YH, Yim J and Kim TK (2000) Identification of mad as a repressor of the human telomerase (hTERT) gene [in process citation]. Oncogene 19: 1485-1490
Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C and DePinho RA (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701-712
Saretzki G, Sitte N, Merkel U, Wurm RE and Zglinicki T (1999) Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments [in process citation]. Oncogene 18: 5148-5158
Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD and Martin GM (1996) Accelerated loss of telomeric repeats may not explain accelerated replicative decline ofWerner syndrome cells. Hum Genet 97: 750-754
Shay JW and Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791
Ulaner GA, Hu JF, Vu TH, Giudice LC and Hoffman AR (1998) Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58: 4168-4172
Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB and Lansdorp PM(1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857-9860
Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D and Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52: 661-667
Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB and Morin GB (1997) Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17: 498-502
Xu D, Wang Q, Gruber A, Bjorkholm M, Chen Z, Zaid A, Selivanova G, Peterson C, Wiman KG and Pisa P (2000) Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells [in process citation]. Oncogene 19: 5123-5133
Xu HJ, Zhou Y, Ji W, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J and Hu SX (1997) Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15: 2589-2596
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, H., Liu, JP. Signaling on telomerase: a master switch in cell aging and immortalization. Biogerontology 3, 107–116 (2002). https://doi.org/10.1023/A:1015232102470
Issue Date:
DOI: https://doi.org/10.1023/A:1015232102470